Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Propofol for Postoperative Delirium in Hip Arthroplasty
NCT02793986Completed
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Aug 2015
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of dexmedetomidine in postoperative delirium (POD) (2 arms), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoints: Incidence of postoperative delirium at 7 days and Mortality in 30 days after surgery. Started Aug 2015; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT02793986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02793986.